Sectors

COR
Cencora, Inc.
323.60
80 x 321.00
40 x 328.68
bid
ask
+
1.57
0.49%
60 @ 07:30 PM
325.00 +1.40 (0.43%)
Ytd-4.19%
1y10.97%
319.04
day range
326.57
244.82
52 week range
377.54
Open321.11Prev Close322.03Low319.04High326.57Mkt Cap61.75B
Vol1.39MAvg Vol1.46MEPS13.53P/E23.92Forward P/E16.36
Beta0.57Short Ratio3.03Inst. Own99.64%Dividend2.40Div Yield0.75
Ex Div Date08-14Earning11-0450-d Avg306.83200-d Avg322.731yr Est369.31

COR News

Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR
defenseworld.net
Connor Clark & Lunn Investment Management Ltd. Invests $841,000 in Cencora, Inc. $COR

Connor Clark and Lunn Investment Management Ltd. acquired a new stake in shares of Cencora, Inc. (NY

Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls Payout ‘Immaterial’
benzinga.com
Walmart Agrees to $50 Million Settlement With DOJ Over Alleged Opioid Prescription Violations, Calls

Walmart agreed to pay $50 million to settle a DOJ lawsuit alleging its pharmacies unlawfully filled

Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance
seekingalpha.com
Invesco Discovery Mid Cap Growth Fund Q2 2026 Portfolio Performance

Invesco Discovery Mid Cap Growth Fund had a positive return and outperformed its benchmark in the se

Advisors Capital Management LLC Takes $748,000 Position in Cencora, Inc. $COR
defenseworld.net
Advisors Capital Management LLC Takes $748,000 Position in Cencora, Inc. $COR

Advisors Capital Management LLC purchased a new stake in shares of Cencora, Inc. (NYSE: COR) in the

$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today
benzinga.com
$100 Invested In Cencora 10 Years Ago Would Be Worth This Much Today

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.61% on an annualized basi

benzinga.com
RBC Capital Initiates Coverage On Cencora with Sector Perform Rating, Announces Price Target of $330

RBC Capital analyst Ryan Halsted initiates coverage on Cencora (NYSE:COR) with a Sector Perform r

"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising Profits.
fool.com
"Trumpflation" Is Real -- and Getting Worse. Here Are 2 Stocks That Turn Rising Prices Into Rising P

These healthcare companies can actually benefit from inflation.

If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today
benzinga.com
If You Invested $1000 In Cencora Stock 10 Years Ago, You Would Have This Much Today

Cencora (NYSE:COR) has outperformed the market over the past 10 years by 6.29% on an annualized basi

benzinga.com
Cencora Says Certain Walgreens Volume Moves Outside Cencora From July 1, 2026; Reaffirms FY26 Adj Di

Beginning July 1, 2026, certain Walgreens volume that was being serviced by Cencora, Inc. (the "

Why Cencora (COR) is a Top Value Stock for the Long-Term
zacks.com
Why Cencora (COR) is a Top Value Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the

Cencora, Inc. (NYSE:COR) Given Average Rating of “Moderate Buy” by Brokerages
defenseworld.net
Cencora, Inc. (NYSE:COR) Given Average Rating of “Moderate Buy” by Brokerages

Shares of Cencora, Inc. (NYSE: COR - Get Free Report) have been assigned a consensus recommendation

Why Cencora (COR) is a Top Momentum Stock for the Long-Term
zacks.com
Why Cencora (COR) is a Top Momentum Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

benzinga.com
Wells Fargo Maintains Overweight on Cencora, Raises Price Target to $395

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and raises the

Here's Why Cencora (COR) is a Strong Growth Stock
zacks.com
Here's Why Cencora (COR) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi

benzinga.com
Morgan Stanley Maintains Overweight on Cencora, Raises Price Target to $346

Morgan Stanley analyst Erin Wright maintains Cencora (NYSE:COR) with a Overweight and raises the

benzinga.com
JP Morgan Maintains Overweight on Cencora, Raises Price Target to $390

JP Morgan analyst Lisa Gill maintains Cencora (NYSE:COR) with a Overweight and raises the price t

Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge
benzinga.com
Terrible Jobs Report Sparks Rally In AI and Tech: 10 Stocks Leading Friday's Surge

Weak U.S. jobs data boosts hopes for a Fed pause, sending AI chip stocks and other high-beta tech na

benzinga.com
Evercore ISI Group Maintains Outperform on Cencora, Raises Price Target to $350

Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and raises

Allspring Growth Fund Q2 2026 Performance Update
seekingalpha.com
Allspring Growth Fund Q2 2026 Performance Update

Allspring Growth Fund outperformed the Russell 3000 Growth Index during the quarter. Sandisk Corp. i

Cencora Q3 Earnings Call Highlights
marketbeat.com
Cencora Q3 Earnings Call Highlights

Cencora NYSE: COR reported fiscal 2026 third-quarter results marked by double-digit adjusted operati

Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript
seekingalpha.com
Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript

Cencora, Inc. (COR) Q3 2026 Earnings Call Transcript

Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
benzinga.com
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

Cencora Inc. (NYSE:COR) on Wednesday reported third-quarter adjusted earnings of $4.48 per share, be

Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins
benzinga.com
Cencora Sees Specialty Growth Continue While GLP-1 Mix Weighs on Margins

Cencora beats third-quarter earnings and revenue estimates, raised fiscal 2026 EPS guidance and main

COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised
zacks.com
COR Stock Gains as Q3 Earnings Beat on Segment Growth, EPS View Raised

Cencora's fiscal Q3 EPS beats estimates as broad segment growth lifts profit, prompting a higher 202

Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
zacks.com
Cencora (COR) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates

Although the revenue and EPS for Cencora (COR) give a sense of how its business performed in the qua

Cencora (COR) Surpasses Q3 Earnings Estimates
zacks.com
Cencora (COR) Surpasses Q3 Earnings Estimates

Cencora (COR) came out with quarterly earnings of $4.48 per share, beating the Zacks Consensus Estim

Cencora lifts annual profit view on strong demand for specialty medicines
reuters.com
Cencora lifts annual profit view on strong demand for specialty medicines

U.S. drug distributor Cencora raised its annual adjusted profit forecast on Wednesday after quarterl

benzinga.com
Cencora Raises FY2026 Adj EPS Guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 Est; Affirms FY

Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.70-$17.90 to $17.75-$17.95 vs $17.79 anal

benzinga.com
Cencora Q3 Adj. EPS $4.48 Beats $4.35 Estimate, Sales $84.754B Beat $84.315B Estimate

Cencora (NYSE:COR) reported quarterly earnings of $4.48 per share which beat the analyst consensus e

Cencora Reports Fiscal 2026 Third Quarter Results
businesswire.com
Cencora Reports Fiscal 2026 Third Quarter Results

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Cencora, Inc. (NYSE: COR) reported that in its fiscal year 2026

What's in Store for These 4 Healthcare Companies This Earnings Season?
zacks.com
What's in Store for These 4 Healthcare Companies This Earnings Season?

McKesson, Cencora, Solventum and PacBio head into earnings with resilient demand offset by tariffs,

FTC takes closer look at Cencora-Covetrus animal health merger, Bloomberg News reports
reuters.com
FTC takes closer look at Cencora-Covetrus animal health merger, Bloomberg News reports

The U.S. Federal Trade Commission is taking ​a closer look at a proposed $3.5 ‌billion acquisition t

Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?
zacks.com
Cencora to Report Q3 Earnings: Is a Beat Likely for the Stock?

COR's Q3 results could reflect specialty pharma strength, oncology expansion and margin gains, even

Kultura Brands Reports Strong Commercial Momentum Following Successful Participation at Cencora ThoughtSpot 2026
accessnewswire.com
Kultura Brands Reports Strong Commercial Momentum Following Successful Participation at Cencora Thou

Company Advances Strategic Pharmacy Relationships, Expands Commercial Pipeline and Positions for Con

benzinga.com
B of A Securities Maintains Neutral on Cencora, Raises Price Target to $285

B of A Securities analyst Michael Funk maintains Cencora (NYSE:COR) with a Neutral and raises the

benzinga.com
Barclays Maintains Overweight on Cencora, Lowers Price Target to $350

Barclays analyst Glen Santangelo maintains Cencora (NYSE:COR) with a Overweight and lowers the pr

Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch
benzinga.com
Amazon Ends Walmart's 13‑Year Hold On The S&P 500 Revenue Crown — But There's A Catch

The battle between Amazon.com and Walmart has produced a new leader for the Fortune 500 list for 202

benzinga.com
Cencora To Support U.S. Distribution Of Gilead Subsidiary Kite's CAR T-Cell Therapies

CONSHOHOCKEN, Pa. [June 2, 2026] — Cencora today announced an agreement with Kite , a Gilead Company

benzinga.com
Cencora Appoints Eva C. Boratto As EVP And CFO

Cencora, Inc. (NYSE:COR) today announced Eva C. Boratto has been appointed Executive Vice President

benzinga.com
If You Invested $100 In Cencora Stock 10 Years Ago, You Would Have This Much Today

benzinga.com
Cencora Raises FY26 Adjusted EPS Range From $17.65 - $17.90 To $17.70 - $17.90; Announces $2B Buybac

Cencora, Inc. (NYSE:COR) today updated its fiscal year 2026 financial guidance as a result of recent

benzinga.com
Wells Fargo Maintains Overweight on Cencora, Lowers Price Target to $331

Wells Fargo analyst Stephen Baxter maintains Cencora (NYSE:COR) with a Overweight and lowers the

benzinga.com
Citigroup Maintains Buy on Cencora, Lowers Price Target to $355

Citigroup analyst Daniel Grosslight maintains Cencora (NYSE:COR) with a Buy and lowers the price

benzinga.com
Evercore ISI Group Maintains Outperform on Cencora, Lowers Price Target to $300

Evercore ISI Group analyst John Belton maintains Cencora (NYSE:COR) with a Outperform and lowers

benzinga.com
Baird Maintains Outperform on Cencora, Lowers Price Target to $339

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and lowers the price t

Earnings Scheduled For May 6, 2026
benzinga.com
Earnings Scheduled For May 6, 2026

Why Is Cencora Stock Trading Lower On Wednesday?
benzinga.com
Why Is Cencora Stock Trading Lower On Wednesday?

Cencora stock falls after Q2 earnings miss and lower sales guidance, despite raising EPS outlook and

S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today
benzinga.com
S&P 500, Nasdaq 100 Smash Records As AMD Jumps 16% On AI Hype: Stock Market Today

U.S. stocks hit records as Trump's Iran memo sinks oil 6%, AMD soars 17% on data-center beat.

benzinga.com
Cencora Raises FY2026 Adj EPS Guidance from $17.45-$17.60 to $17.65-$17.90 vs $17.60 Est; Lowers FY2

Cencora (NYSE:COR) raises FY2026 Adj EPS guidance from $17.45-$17.60 to $17.65-$17.90 vs $17.60 anal

benzinga.com
Cencora Q2 Adj. EPS $4.75 Misses $4.81 Estimate, Sales $78.356B Miss $81.093B Estimate

Cencora (NYSE:COR) reported quarterly earnings of $4.75 per share which missed the analyst consensus